Comparative pharmacology of cholecystokinin induced activation of cultured vagal afferent neurons from rats and mice

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Kinch, Dallas C ^a   Peters, James H ^a   Simasko, Steven M ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CAPSAICIN; CHOLECYSTOKININ; CHOLECYSTOKININ OCTAPEPTIDE; N TERT BUTYLOXYCARBONYLCHOLECYSTOKININ[27-32][28,31 NORLEUCINE] PHENETHYL ESTER; RUTHENIUM RED;

ANIMAL CELL; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CALCIUM TRANSPORT; CELL ACTIVATION; CELL ACTIVITY; CELL CULTURE; CELL ISOLATION; CELL SUBPOPULATION; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); DRUG ACTIVITY; FLUORESCENCE IMAGING; MALE; MOUSE; NERVE CELL MEMBRANE STEADY POTENTIAL; NODOSE GANGLION; NONHUMAN; RAT; SENSORY NERVE; SPRAGUE DAWLEY RAT; VAGAL AFFERENT NEURON; ANIMAL; C57BL MOUSE; CYTOLOGY; DRUG EFFECT; METABOLISM; SENSORY NERVE CELL; VAGUS NERVE;

MUS; RATTUS;

ANIMALS; CELLS, CULTURED; CHOLECYSTOKININ; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEURONS, AFFERENT; NODOSE GANGLION; RATS; RATS, SPRAGUE-DAWLEY; VAGUS NERVE;

EID: 84859705624     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034755     Document Type: Article

References (56)

1. Ritter RC, (2004) Gastrointestinal mechanisms of satiation for food. Physiol Behav 81: 249-273.
2. Berthoud HR, Neuhuber WL, (2000) Functional and chemical anatomy of the afferent vagal system. Auton Neurosci 85: 1-17.
3. Dockray GJ, (2009) Cholecystokinin and gut-brain signalling. Regul Pept 155 6-10. S0167-0115(09)00075-5 [pii];10.1016/j.regpep.2009.03.015 [doi].
4. Grundy D, (2006) Signalling the state of the digestive tract. Auton Neurosci 125 76-80. S1566-0702(06)00012-9 [pii];10.1016/j.autneu.2006.01.009 [doi].
5. Peters JH, Ritter RC, Simasko SM, (2006) Leptin and CCK selectively activate vagal afferent neurons innervating the stomach and duodenum. Am J Physiol Regul Integr Comp Physiol 290 R1544-R1549. 00811.2005 [pii];10.1152/ajpregu.00811.2005 [doi].
6. Dun NJ, Wu SY, Lin CW, (1991) Excitatory effects of cholecystokinin octapeptide on rat nodose ganglion cells in vitro. Brain Res 556: 161-164.
7. Lankisch TO, Tsunoda Y, Lu Y, Owyang C, (2002) Characterization of CCK(A) receptor affinity states and Ca(2+) signal transduction in vagal nodose ganglia. Am J Physiol Gastrointest Liver Physiol 282 G1002-G1008. 10.1152/ajpgi.00313.2001 [doi].
8. Simasko SM, Wiens J, Karpiel A, Covasa M, Ritter RC, (2002) Cholecystokinin increases cytosolic calcium in a subpopulation of cultured vagal afferent neurons. Am J Physiol Regul Integr Comp Physiol 283 R1303-R1313. 10.1152/ajpregu.00050.2002 [doi];00050.2002 [pii].
9. Widdop RE, Krstew E, Mercer LD, Carlberg M, Beart PM, et al. (1994) Electrophysiological and autoradiographical evidence for cholecystokinin A receptors on rat isolated nodose ganglia. J Auton Nerv Syst 46: 65-73.
10. Heldsinger A, Grabauskas G, Song I, Owyang C, (2011) Synergistic interaction between leptin and cholecystokinin in the rat nodose ganglia is mediated by PI3K and STAT3 signaling pathways: implications for leptin as a regulator of short term satiety. J Biol Chem 286 11707-11715. M110.198945 [pii];10.1074/jbc.M110.198945 [doi].
11. Peters JH, Ritter RC, Simasko SM, (2005) Leptin and CCK modulate complementary background conductances to depolarize cultured nodose neurons. Am J Physiol Cell Physiol.
12. Simasko SM, Ritter RC, (2003) Cholecystokinin Activates Both A-Type and C-Type Vagal Afferent Neurons. Am J Physiol Gastrointest Liver Physiol.
13. Zhao H, Simasko SM, (2010) Role of transient receptor potential channels in cholecystokinin-induced activation of cultured vagal afferent neurons. Endocrinology 151 5237-5246. en.2010-0504 [pii];10.1210/en.2010-0504 [doi].
14. Cawston EE, Miller LJ, (2010) Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor. Br J Pharmacol 159 1009-1021. BPH489 [pii];10.1111/j.1476-5381.2009.00489.x [doi].
15. Williams JA, Sans MD, Tashiro M, Schafer C, Bragado MJ, et al. (2002) Cholecystokinin activates a variety of intracellular signal transduction mechanisms in rodent pancreatic acinar cells. Pharmacol Toxicol 91: 297-303.
16. Li Y, Wu X, Zhou S, Owyang C, (2011) Low-affinity CCK-A receptors are coexpressed with leptin receptors in rat nodose ganglia: implications for leptin as a regulator of short-term satiety. Am J Physiol Gastrointest Liver Physiol 300 G217-G227. ajpgi.00356.2010 [pii];10.1152/ajpgi.00356.2010 [doi].
17. Weatherford SC, Laughton WB, Salabarria J, Danho W, Tilley JW, et al. (1993) CCK satiety is differentially mediated by high- and low-affinity CCK receptors in mice and rats. Am J Physiol 264: R244-R249.
18. Zhao H, Sprunger LK, Simasko SM, (2010) Expression of transient receptor potential channels and two-pore potassium channels in subtypes of vagal afferent neurons in rat. Am J Physiol Gastrointest Liver Physiol 298 G212-G221. ajpgi.00396.2009 [pii];10.1152/ajpgi.00396.2009 [doi].
19. Zhang L, Jones S, Brody K, Costa M, Brookes SJ, (2004) Thermosensitive transient receptor potential channels in vagal afferent neurons of the mouse. Am J Physiol Gastrointest Liver Physiol 286 G983-G991. 10.1152/ajpgi.00441.2003 [doi];00441.2003 [pii].
20. Matozaki T, Martinez J, Williams JA, (1989) A new CCK analogue differentiates two functionally distinct CCK receptors in rat and mouse pancreatic acini. Am J Physiol 257: G594-G600.
21. Crawley JN, Belknap JK, Collins A, Crabbe JC, Frankel W, et al. (1997) Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology (Berl) 132: 107-124.
22. de Jonge WJ, van der Zanden EP, The FO, Bijlsma MF, van Westerloo DJ, et al. (2005) Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 6: 844-851.
23. Gaisano GG, Park SJ, Daly DM, Beyak MJ, (2010) Glucagon-like peptide-1 inhibits voltage-gated potassium currents in mouse nodose ganglion neurons. Neurogastroenterol Motil 22 470-9, e111. NMO1430 [pii];10.1111/j.1365-2982.2009.01430.x [doi].
24. Duclaux R, Mei N, Ranieri F, (1976) Conduction velocity along the afferent vagal dendrites: a new type of fibre. J Physiol 260: 487-495.
25. Holzer P, (1991) Capsaicin: Cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 43: 143-201.
26. Chung E, Gu Q, Kwong K, Arden WA, Lee LY, (2002) Comparison of capsaicin-evoked calcium transients between rat nodose and jugular ganglion neurons. Auton Neurosci 97 83-88. S1566-0702(02)00045-0 [pii].
27. Wank SA, (1995) Cholecystokinin receptors. Am J Physiol 269: G628-G646.
28. Yule DI, Tseng MJ, Williams JA, Logdson CD, (1993) A cloned CCK-A receptor transduces multiple signals in response to full and partial agonists. Am J Physiol 265: 999-1004.
29. Bianchi BR, Miller TR, Witte DG, Lin CW, (1994) Novel CCK analogues and bombesin: a detailed analysis between phosphoinositide breakdown and high-dose inhibition of pancreatic enzyme secretion in three rodent species. J Pharmacol Exp Ther 268: 996-1002.
30. Schwartz GJ, McHugh PR, Moran TH, (1994) Pharmacological dissociation of responses to CCK and gastric loads in rat mechanosensitive vagal afferents. Am J Physiol 267: R303-R308.
31. Archer-Lahlou E, Escrieut C, Clerc P, Martinez J, Moroder L, et al. (2005) Molecular mechanism underlying partial and full agonism mediated by the human cholecystokinin-1 receptor. J Biol Chem 280 10664-10674. M409451200 [pii];10.1074/jbc.M409451200 [doi].
32. Sarri E, Ramos B, Salido GM, Claro E, (2001) The cholecystokinin analogues JMV-180 and CCK-8 stimulate phospholipase C through the same binding site of CCK(A) receptor in rat pancreatic acini. Br J Pharmacol 133 1227-1234. 10.1038/sj.bjp.0704190 [doi].
33. Sato S, Stark HA, Martinez J, Beaven MA, Jensen RT, et al. (1989) Receptor occupation, calcium mobilization, and amylase release in pancreatic acini: effect of CCK-JMV-180. Am J Physiol 257: G202-G209.
34. Ritter RC, Ladenheim EE, (1985) Capsaicin pretreatment attenuates suppression of food intake by cholecystokinin. Am J Physiol 248: R501-R504.
35. Ralevic V, Jerman JC, Brough SJ, Davis JB, Egerton J, et al. (2003) Pharmacology of vanilloids at recombinant and endogenous rat vanilloid receptors. Biochem Pharmacol 65 143-151. S000629520201451X [pii].
36. Smart D, Jerman JC, Gunthorpe MJ, Brough SJ, Ranson J, et al. (2001) Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology. Eur J Pharmacol 417 51-58. S0014-2999(01)00901-3 [pii].
37. Correll CC, Phelps PT, Anthes JC, Umland S, Greenfeder S, (2004) Cloning and pharmacological characterization of mouse TRPV1. Neurosci Lett 370 55-60. S0304-3940(04)00941-3 [pii];10.1016/j.neulet.2004.07.058 [doi].
38. Peters JH, McDougall SJ, Fawley JA, Smith SM, Andresen MC, (2010) Primary afferent activation of thermosensitive TRPV1 triggers asynchronous glutamate release at central neurons. Neuron 65 657-669. S0896-6273(10)00108-X [pii];10.1016/j.neuron.2010.02.017 [doi].
39. Shoudai K, Peters JH, McDougall SJ, Fawley JA, Andresen MC, (2010) Thermally active TRPV1 tonically drives central spontaneous glutamate release. J Neurosci 30 14470-14475. 30/43/14470 [pii];10.1523/JNEUROSCI.2557-10.2010 [doi].
40. Peters JH, Karpiel AB, Ritter RC, Simasko SM, (2004) Cooperative activation of cultured vagal afferent neurons by leptin and cholecystokinin. Endocrinology 145 3652-3657. 10.1210/en.2004-0221 [doi];en.2004-0221 [pii].
41. Powley TL, Phillips RJ, (2002) Musings on the wanderer: what's new in our understanding of vago-vagal reflexes? I. Morphology and topography of vagal afferents innervating the GI tract. Am J Physiol Gastrointest Liver Physiol 283 G1217-G1225. 10.1152/ajpgi.00249.2002 [doi];00249.2002 [pii].
42. Weatherford SC, Chiruzzo FY, Laughton WB, (1992) Satiety induced by endogenous and exogenous cholecystokinin is mediated by CCK-A receptors in mice. Am J Physiol 262: R574-R578.
43. Wank SA, (1998) G protein-coupled receptors in gastrointestinal physiology I. CCK receptors: an exemplary family. Am J Physiol 274: G607-G613.
44. Fulcrand P, Rodriguez M, Galas MC, Lignon MF, Laur J, et al. (1988) 2-Phenylethyl ester and 2-phenylethyl amide derivative analogues of the C-terminal hepta- and octapeptide of cholecystokinin. Int J Pept Protein Res 32: 384-395.
45. Galas MC, Lignon MF, Rodriguez M, Mendre C, Fulcrand P, et al. (1988) Structure-activity relationship studies on cholecystokinin: analogues with partial agonist activity. Am J Physiol 254: G176-G182.
46. Rodriguez M, Lignon MF, Galas MC, Fulcrand P, Mendre C, et al. (1987) Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds. J Med Chem 30: 1366-1373.
47. Stark HA, Sharp CM, Sutliff VE, Martinez J, Jensen RT, et al. (1989) CCK-JMV-180: a peptide that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors. Biochim Biophys Acta 1010 145-150. 0167-4889(89)90154-7 [pii].
48. Lankisch TO, Nozu F, Owyang C, Tsunoda Y, (1999) High-affinity cholecystokinin type A receptor/cytosolic phospholipase A2 pathways mediate Ca2+ oscillations via a positive feedback regulation by calmodulin kinase in pancreatic acini. Eur J Cell Biol 78: 632-641.
49. Tsunoda Y, Owyang C, (1995) High-affinity CCK receptors are coupled to phospholipase A2 pathways to mediate pancreatic amylase secretion. Am J Physiol 269: G435-G444.
50. Saluja AK, Dawra RK, Lerch MM, Steer ML, (1992) CCK-JMV-180, an analog of cholecystokinin, releases intracellular calcium from an inositol trisphosphate-independent pool in rat pancreatic acini. J Biol Chem 267: 11202-11207.
51. Yule DI, Williams JA, (1992) U73122 inhibits Ca2+ oscillations in response to cholecystokinin and carbachol but not to JMV-180 in rat pancreatic acinar cells. J Biol Chem 267: 13830-13835.
52. Zhao H, Kinch DC, Simasko SM, (2011) Pharmacological investigations of the cellular transduction pathways used by cholecystokinin to activate nodose neurons. Auton Neurosci. S1566-0702(11)00099-3 [pii];10.1016/j.autneu.2011.05.004 [doi].
53. Ghanekar D, Hadac EM, Holicky EL, Miller LJ, (1997) Differences in partial agonist action at cholecystokinin receptors of mouse and rat are dependent on parameters extrinsic to receptor structure: molecular cloning, expression and functional characterization of the mouse type A cholecystokinin receptor. J Pharmacol Exp Ther 282: 1206-1212.
54. Ji B, Kopin AS, Logsdon CD, (2000) Species differences between rat and mouse CCKA receptors determine the divergent acinar cell response to the cholecystokinin analog JMV-180. J Biol Chem 275 19115-19120. 10.1074/jbc.M001685200 [doi];M001685200 [pii].
55. Poosti R, di ML, Gagne D, Bernad N, Galleyrand JC, Escrieut C, et al. (2000) The third intracellular loop of the rat and mouse cholecystokinin-A receptors is responsible for different patterns of gene activation. Mol Pharmacol 58: 1381-1388.
56. Crawley JN, Corwin RL, (1994) Biological actions of cholecystokinin. Peptides 15 731-755. 0196-9781(94)90104-X [pii].